Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938

Applied and Environmental Microbiology

Volumn 74, Issue 19, 2008, Pages 6032-6040

  Rosander, Anna ^a   Connolly, Eamonn ^b   Roos, Stefan ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b BioGaia AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDS; ANTIBIOTICS; BIOMARKERS; ELECTRIC LOAD MANAGEMENT; GENES; LACTIC ACID; ORGANIC ACIDS; PORTS AND HARBORS; STRAIN;

ANTIBIOTIC RESISTANCES; BINDING PROTEINS; GASTROINTESTINAL TRACTS; GENETICALLY MODIFIED; HUMAN CLINICAL TRIALS; IN VITRO; LACTIC ACID BACTERIA; LACTOBACILLUS REUTERI; LINCOSAMIDE; PROBIOTIC; PROBIOTIC STRAINS; RESISTANCE GENES; RESISTANT STRAINS;

ACID RESISTANCE;

BETA LACTAM; LINCOSAMIDE; PENICILLIN BINDING PROTEIN; PROBIOTIC AGENT; TETRACYCLINE; ANTIINFECTIVE AGENT; BACTERIAL DNA;

ANTIBIOTIC RESISTANCE; BACTERIUM; COMPARATIVE STUDY; PATHOGEN; PLASMID; PROBIOTICS;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; CONTROLLED STUDY; FEMALE; GENE LOCATION; GENE SEQUENCE; HUMAN; HUMAN CELL; LACTOBACILLUS REUTERI; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PLASMID; SPECIES COMPARISON; UNINDEXED SEQUENCE; ADOLESCENT; AGED; AMINO ACID SEQUENCE; BACTERIAL GENE; CHEMISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DNA SEQUENCE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; GENETICS; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; MOLECULAR GENETICS; RANDOMIZED CONTROLLED TRIAL; SEQUENCE ALIGNMENT;

LACTOBACILLUS REUTERI;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; DNA, BACTERIAL; DOUBLE-BLIND METHOD; DRUG RESISTANCE, BACTERIAL; FEMALE; GENES, BACTERIAL; HUMANS; LACTOBACILLUS REUTERI; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PLASMIDS; PROBIOTICS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA;

EID: 54449092724     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.00991-08     Document Type: Article

References (48)

1. Abrahamsson, T. R., T. Jakobsson, M. F. Böttcher, M. Fredrikson, M. C. Jenmalm, B. Björkstén, and G. Oldaeus. 2007. Probiotics in prevention of IgE-associated eczema: a double blind randomised placebo-controlled trial. J. Allergy Clin. Immunol. 119:1174-1180.
2. Achard, A., C. Villers, V. Pichereau, and R. Leclercq. 2005. New lnu(C) gene conferring resistance to lincomycin by nucleotidylation in Streptococcus agalactiae UCN36. Antimicrob. Agents Chemother. 49:2716-2719.
3. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
4. Aminov, R. I., N. Garrigues-Jeanjean, and R. I. Mackie. 2001. Molecular ecology of tetracycline resistance: development and validation of primers for detection of tetracycline resistance genes encoding ribosomal protection proteins. Appl. Environ. Microbiol. 67:22-32.
5. Barbosa, T. M., K. P. Scott, and H. J. Flint. 1999. Evidence for recent intergeneric transfer of a new tetracycline resistance gene, tet(W), isolated from Butyrivibrio fibrisolvens, and the occurrence of tet(O) in ruminal bacteria. Environ. Microbiol. 1:53-64.
6. Barlow, S., A. Chesson, J. D. Collins, E. Dybing, A. Flynn, C. Fruijtier-Pölloth, A. Hardy, A. Knaap, H. Kuiper, P. Le Neindre, J. Schans, J. Schlatter, V. Silano, S. Skerfving, and P. Vannier. 2007. Introduction of a qualified presumption of safety (QPS) approach for assessment of selected microorganisms referred to EFSA. Opinion of the Scientific Committee. Eur. Food Saf. Authority J. 587:1-16.
7. Båth, K., S. Roos, T. Wall, and H. Jonsson. 2005. The cell surface of Lactobacillus reuteri ATCC 55730 highlighted by identification of 126 extracellular proteins from the genome sequence. FEMS Microbiol. Lett. 253:75-82.
8. Borriello, S. P., W. P. Hammes, W. Holzapfel, P. Marteau, J. Schrezenmeir, M. Vaara, and V. Valtonen. 2003. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin. Infect. Dis. 36:775-780.
9. Bozdogan, B., L. Berrezouga, M. Kuo, D. Yurek, K. Farley, B. Stockman, and R. Leclercq. 1999. A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025. Antimicrob. Agents Chemother. 43:925-929.
10. Brisson-Noël, A., and P. Courvalin. 1986. Nucleotide sequence of gene linA encoding resistance to lincosamide in Staphylococcus haemolyticus. Gene 43:247-253.
11. Brisson-Noël, A., P. Delrieu, D. Samain, and P. Courvalin. 1988. Inactivation of lincosamide O-nucleotidyltransferases and comparison of the corresponding resistance gene. J. Biol. Chem. 263:15880-15887.
12. Chin, S. C., N. Abdullah, T. W. Siang, and H. Y. Wan. 2005. Plasmid profiling and curing of Lactobacillus strains isolated from the gastrointestinal tract of chicken. J. Microbiol. 43:251-256.
13. Chung, T. C., L. Axelsson, S. E. Lindgren, and W. J. Dobrogosz. 1989. In vitro studies on reuterin synthesis by Lactobacillus reuteri. Microb. Ecol. Health Dis. 2:137-144.
14. Coffey, T. J., C. G. Dowson, M. Daniels, and B. G. Spratt. 1995. Genetics and molecular biology of beta-lactam-resistant pneumococci. Microb. Drug. Resist. 1:29-34.
15. Cotter, P. D., C. G. Gahan, and C. Hill. 2001. A glutamate decarboxylase system protects Listeria monocytogenes in gastric fluid. Mol. Microbiol. 40: 465-475.
16. Courvalin, P. 2006. Antibiotic resistance: the pros and cons of probiotics. Dig. Liver Dis. Suppl. 2:S261-S265.
17. Curragh, H. J., and M. A. Collins. 1992. High levels of spontaneous drug resistance in Lactobacillus. J. Appl. Bacteriol. 73:31-36.
18. Egervärn, M., M. Danielsen, S. Roos, H. Lindmark, and S. Lindgren. 2007. Antibiotic susceptibility profiles of Lactobacillus reuteri and Lactobacillus fermentum. J. Food Protect. 70:412-418.
19. Egervärn, M., H. Lindmark, S. Roos, G. Huys, and S. Lindgren. 2007. Effects of inoculum size and incubation time on broth microdilution susceptibility testing of lactic acid bacteria. Antimicrob. Agents Chemother. 51:394-396.
20. Glintborg, V., S. Dawids, J. Preuss Hasselby, H. Winther Nielsen, and A. Mertz Nielsen. 2006. Long-term administration of Lactobacillus reuteri (ATCC55730) has no influence on gastric mucosal inflammation and colonization of Helicobacter pylori in humans. A pilot study. Int. J. Probiotics Prebiotics 1:225-232.
21. Hiramatsu, K., Y. Katayama, H. Yuzawa, and T. Ito. 2002. Molecular genetics of methicillin-resistant Staphylococcus aureus. Int. J. Med. Microbiol. 292:67-74.
22. Hiramatsu, K., M. Ohama, Y. Mijajima, K. Kishi, S. Mizunoe, I. Tokimatsu, H. Nagai, J. Kadota, T. Saikawa, and M. Nasu. 2004. Antimicrobial susceptibilities and analysis of genes related to penicillin or macrolide resistance in Streptococcus pneumoniae. Int. J. Antimicrob. Agents 24:125-129.
23. Indrio, F., G. Riezzo, F. Raimondi, M. Bisceglia, L. Cavallo, and R. Francavilla. 2008. The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns. J. Pediatr. 152:801-806.
24. Kastner, S., V. Perreten, H. Bleuler, G. Hugenschmidt, C. Lacroix, and L. Miele. 2006. Antibiotic susceptibility patterns and resistance genes of starter cultures and probiotic bacteria used in food. Syst. Appl. Microbiol. 29:145-155.
25. Klare, I., C. Konstabel, G. Werner, G. Huys, V. Vankerckhoven, G. Kahlmeter, B. Hilderbrandt, S. Müller-Bertling, W. Witte, and H. Goossens. 2007. Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococus human isolates and cultures intended for probiotic or nutritional use. J. Antimicrob. Chemother. 59:900-912.
26. Klein, G., C. Hallmann, I. A. Casas, J. Abad, J. Louwers, and G. Reuter. 2000. Exclusion of vanA, vanB and vanC type glycopeptide resistance in strains of Lactobacillus reuteri and Lactobacillus rhamnosus used as probiotics by polymerase chain reaction and hybridization methods. J. Appl. Microbiol. 89:815-824.
27. Lionetti, E., V. L. Miniello, S. P. Castellaneta, A. DeCanio, A. M. Magista, A. DeCanio, M. Giovanni, F. Ierardi, L. Cavallo, and R. Francavilla. 2006. Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomised placebo controlled trial. Aliment. Pharmacol. Ther. 24:1461-1468.
28. Liu, M. L., J. K. Kondo, M. B. Barnes, and D. T. Bartholomew. 1988. Plasmid-linked maltose utilization in Lactobacillus ssp. Biochimie 70:351-355.
29. Perreten, V., N. Giampa, U. Schuler-Schmid, and M. Teuber. 1998. Antibiotic resistance genes in coagulase-negative staphylococci isolated from food. Syst. Appl. Microbiol. 21:113-120.
30. Philippon, A., G. Arlet, and G. A. Jacoby. 2002. Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother. 46:1-11.
31. Roos, S., F. Karner, L. Axelsson, and H. Jonsson. 2000. Lactobacillus mucosae sp. nov., a new species with in vitro mucus-binding activity isolated from pig intestine. Int. J. Syst. Evol. Microbiol. 50:251-258.
32. Ruiz-Barba, J. L., J. C. Piard, and R. Jimenez-Diaz. 1991. Plasmid profiles and curing of plasmids in Lactobacillus plantarum strains isolated from green olive fermentations. J. Appl. Bacteriol. 71:417-421.
33. Sarra, P. G., M. Vescovo, and M. Fulgoni. 1986. Study on crop adhesion genetic determinant in Lactobacillus reuteri. Microbiologica 9:279-285.
34. Savino, F., E. Pelle, E. Palumeri, R. Oggero, and R. Miniero. 2007. Lactobacillus reuteri (American Type Culture Collection strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics 119:124-130.
35. Scott, K. P., C. M. Melville, T. M. Barbosa, and H. J. Flint. 2000. Occurrence of the new tetracycline resistance gene tet(W) in bacteria from the human gut. Antimicrob. Agents Chemother. 44:775-777.
36. Tanaka, O., and S. Ohmomo. 2001. Efficient protoplast regeneration for some homofermentative lactobacilli and pediococci. Arch. Microbiol. 177: 36-40.
37. Teuber, M. 1999. Spread of antibiotic resistance with food-borne pathogens. Cell. Mol. Life Sci. 56:755-763.
38. Teuber, M., L. Meile, and F. Schwarz. 1999. Acquired antibiotic resistance in lactic acid bacteria from food. Antonie van Leeuwenhoek 76:115-137.
39. Valeur, N., P. Engel, N. Carbajal, E. Connolly, and K. Ladefoged. 2004. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl. Environ. Microbiol. 70:1176-1181.
40. Vankerckhoven, V., G. Huys, M. Vancanneyt, C. Vael, I. Klare, M.-B. Romond, J. M. Entenza, P. Moreillon, R. D. Wind, J. Knol, E. Wiertz, B. Pot, E. E. Vaughan, G. Kahlmeter, and H. Goossens. 2008. Biosafety assessment of probiotics used for human consumption: recommendations from the EUPROSAFE project. Trends Food Sci. Technol. 19:102-114.
41. Versalovic, J., M. Schneider, F. de Bruijn, and J. Lupski. 1994. Genomic fingerprinting of bacteria using repetitive sequence-based polymerase chain reaction. Methods Mol. Cell. Biol. 5:25-40.
42. Vescovo, M., L. Morelli, and V. Bottazzi. 1982. Drug resistance plasmids in Lactobacillus acidophilus and Lactobacillus reuteri. Appl. Environ. Microbiol. 43:50-56.
43. Vescovo, M., L. Morelli, P. S. Cocconcelli, and V. Bottazzi. 1984. Protoplast formation, regeneration and plasmid curing in Lactobacillus reuteri. FEMS Microbiol. Lett. 23:333-334.
44. Villedieu, A., M. L. az-Torres, N. Hunt, R. McNab, D. A. Spratt, M. Wilson, and P. Mullany. 2003. Prevalence of tetracycline resistance genes in oral bacteria. Antimicrob. Agents Chemother. 47:878-882.
45. Wall, T., K. Båth, R. A. Britton, H. Jonsson, J. Versalovic, and S. Roos. 2007. The early response to acid shock in Lactobacillus reuteri involves the ClpL chaperone and a putative cell wall-altering esterase. Appl. Environ. Microbiol. 73:3924-3935.
46. Weizman, Z., G. Asli, and A. Alsheikh. 2005. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 115:5-9.
47. Wolf, B. W., K. Garleb, D. Ataya, and I. A. Casas. 1995. Safety and tolerance of Lactobacillus reuteri in healthy adults male subjects. Microb. Ecol. Health Dis. 8:41-50.
48. Wolf, B. W., K. Wheeler, D. Ataya, and K. Garleb. 1998. Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus. Food Chem. Toxicol. 36:1085-1094.